Brief: Sobi Raises Outlook For 2026 Revenue Growth
27/10/2026 07:07
BRIEF-Sobi Raises Outlook For 2026 Revenue Growth Oct 27 (Reuters) - Swedish Orphan Biovitrum AB (publ) SOBIV.ST:
TOTAL REVENUE INCREASED 16 PER CENT AT CER (CONSTANT EXCHANGE RATES), 17 PER CENT AT ACTUAL RATES, TO SEK 9,124 M (7,776)
EBITA WAS SEK 3,990 M (3,620), CORRESPONDING TO A MARGIN OF 44 PER CENT (47)
OUTLOOK 2026 - UPDATED: REVENUE IS ANTICIPATED TO GROW BY HIGH-TEENS TO LOW-20S% AT CER (PREVIOUSLY, MID- TO HIGH-TEENS %)
Q3 2026 CASH FLOW FROM OPERATING ACTIVITIES WAS SEK 1,871 MILLION
Source text: ID:nWkr5hLVsP
Further company coverage: SOBIV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Swedish Orphan Biovitrum AB (publ)
See all newsTop of the Street: SOBI, Sonova, BAT, Imperial Brands
SOBI slips after Ionis lowers Tryngolza sales forecast
Brief: Swedish Orphan Biovitrum Executive Sells, Buys Shares
Europe Research Roundup: Centrica, Fuchs, URW
Brief: Swedish Orphan Biovitrum Proposes Börje Ekholm As New Chair And Board Member At 2027 AGM